Loss of keratin 23 enhances growth inhibitory effect of melatonin in gastric cancer
- Authors:
- Li Li
- Meifang Lin
- Jianhua Luo
- Huaqin Sun
- Zhiguang Zhang
- Dacen Lin
- Lushan Chen
- Sisi Feng
- Xiuping Lin
- Ruixiang Zhou
- Jun Song
-
Affiliations: Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, Fujian 350108, P.R. China, Department of Pathology, Affiliated Zhongshan Hospital of Xiamen University, Xiamen, Fujian 361004, P.R. China, Center of Translational Hematology, Fujian Medical University, Fuzhou, Fujian 350001, P.R. China, Department of Pathology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China - Published online on: December 12, 2023 https://doi.org/10.3892/mmr.2023.13145
- Article Number: 22
-
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI |
|
Huang C, Yuan W, Lai C, Zhong S, Yang C, Wang R, Mao L and Chen Z and Chen Z: EphA2-to-YAP pathway drives gastric cancer growth and therapy resistance. Int J Cancer. 146:1937–1949. 2020. View Article : Google Scholar : PubMed/NCBI |
|
Liu Z, Ran H, Wang Z, Zhou S and Wang Y: Targeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect. Int J Nanomedicine. 14:7627–7642. 2019. View Article : Google Scholar : PubMed/NCBI |
|
Liu Z, Yu S, Ye S, Shen Z, Gao L, Han Z, Zhang P, Luo F, Chen S and Kang M: Keratin 17 activates AKT signalling and induces epithelial-mesenchymal transition in oesophageal squamous cell carcinoma. J Proteomics. 211:1035572020. View Article : Google Scholar : PubMed/NCBI |
|
Wang PB, Chen Y, Ding GR, Du HW and Fan HY: Keratin 18 induces proliferation, migration, and invasion in gastric cancer via the MAPK signalling pathway. Clin Exp Pharmacol Physiol. 48:147–156. 2021. View Article : Google Scholar : PubMed/NCBI |
|
Chen B, Xu X, Lin DD, Chen X, Xu YT, Liu X and Dong WG: KRT18 modulates alternative splicing of genes involved in proliferation and apoptosis processes in both gastric cancer cells and clinical samples. Front Genet. 12:6354292021. View Article : Google Scholar : PubMed/NCBI |
|
Birkenkamp-Demtroder K, Hahn SA, Mansilla F, Thorsen K, Maghnouj A, Christensen R, Øster B and Ørntoft TF: Keratin23 (KRT23) knockdown decreases proliferation and affects the DNA damage response of colon cancer cells. PLoS One. 8:e735932013. View Article : Google Scholar : PubMed/NCBI |
|
Kim D, Brocker CN, Takahashi S, Yagai T, Kim T, Xie G, Wang H, Qu A and Gonzalez FJ: Keratin 23 is a peroxisome proliferator-activated receptor alpha-dependent, MYC-amplified oncogene that promotes hepatocyte proliferation. Hepatology. 70:154–167. 2019. View Article : Google Scholar : PubMed/NCBI |
|
Ren M, Gao Y, Chen Q, Zhao H, Zhao X and Yue W: The overexpression of keratin 23 promotes migration of ovarian cancer via epithelial-mesenchymal transition. Biomed Res Int. 2020:82187352020. View Article : Google Scholar : PubMed/NCBI |
|
Florido J, Martinez-Ruiz L, Rodriguez-Santana C, López-Rodríguez A, Hidalgo-Gutiérrez A, Cottet-Rousselle C, Lamarche F, Schlattner U, Guerra-Librero A, Aranda-Martínez P, et al: Melatonin drives apoptosis in head and neck cancer by increasing mitochondrial ROS generated via reverse electron transport. J Pineal Res. 73:e128242022. View Article : Google Scholar : PubMed/NCBI |
|
Hsiao SY, Tang CH, Chen PC, Lin TH and Chao CC: Melatonin inhibits EMT in bladder cancer by targeting autophagy. Molecules. 27:86492022. View Article : Google Scholar : PubMed/NCBI |
|
Hasan M, Marzouk MA, Adhikari S, Wright TD, Miller BP, Matossian MD, Elliott S, Wright M, Alzoubi M, Collins-Burow BM, et al: Pharmacological, mechanistic, and pharmacokinetic assessment of novel melatonin-tamoxifen drug conjugates as breast cancer drugs. Mol Pharmacol. 96:272–296. 2019. View Article : Google Scholar : PubMed/NCBI |
|
Hao J, Fan W, Li Y, Tang R, Tian C, Yang Q, Zhu T, Diao C, Hu S, Chen M, et al: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits. J Exp Clin Cancer Res. 38:482019. View Article : Google Scholar : PubMed/NCBI |
|
Wang Q, Sun Z, Du L, Xu C, Wang Y, Yang B, He N, Wang J, Ji K, Liu Y and Liu Q: Melatonin Sensitizes human colorectal cancer cells to gamma-ray ionizing radiation in vitro and in vivo. Int J Mol Sci. 19:39742018. View Article : Google Scholar : PubMed/NCBI |
|
JG DEA, Serra LSM, Lauand L, Kuckelhaus SAS and Sampaio ALL: Protective effect of melatonin on cisplatin-induced ototoxicity in rats. Anticancer Res. 39:2453–2458. 2019. View Article : Google Scholar : PubMed/NCBI |
|
Palmer ACS, Zortea M, Souza A, Santos V, Biazús JV, Torres ILS, Fregni F and Caumo W: Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial. PLoS One. 15:e02313792020. View Article : Google Scholar : PubMed/NCBI |
|
Song J, Ma SJ, Luo JH, Zhang H, Wang RX, Liu H, Li L, Zhang ZG and Zhou RX: Melatonin induces the apoptosis and inhibits the proliferation of human gastric cancer cells via blockade of the AKT/MDM2 pathway. Oncol Rep. 39:1975–1983. 2018.PubMed/NCBI |
|
Wang RX, Liu H, Xu L, Zhang H and Zhou RX: Involvement of nuclear receptor RZR/RORgamma in melatonin-induced HIF-1alpha inactivation in SGC-7901 human gastric cancer cells. Oncol Rep. 34:2541–2546. 2015. View Article : Google Scholar : PubMed/NCBI |
|
Ao L, Yan H, Zheng T, Wang H, Tong M, Guan Q, Li X, Cai H, Li M and Guo Z: Identification of reproducible drug-resistance-related dysregulated genes in small-scale cancer cell line experiments. Sci Rep. 5:118952015. View Article : Google Scholar : PubMed/NCBI |
|
Benjamini Y and Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B. 57:289–300. 1995. |
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI |
|
Ao L, Li L, Sun H, Chen H, Li Y, Huang H, Wang X, Guo Z and Zhou R: Transcriptomic analysis on the effects of melatonin in gastrointestinal carcinomas. BMC Gastroenterol. 20:2332020. View Article : Google Scholar : PubMed/NCBI |
|
Bubenik GA: Thirty four years since the discovery of gastrointestinal melatonin. J Physiol Pharmacol. 59 (Suppl 2):S33–S51. 2008. |
|
Asghari MH, Moloudizargari M, Ghobadi E, Fallah M and Abdollahi M: Melatonin as a multifunctional anti-cancer molecule: Implications in gastric cancer. Life Sci. 185:38–45. 2017. View Article : Google Scholar : PubMed/NCBI |
|
Bubenik GA: Gastrointestinal melatonin: Localization, function, and clinical relevance. Dig Dis Sci. 47:2336–2348. 2002. View Article : Google Scholar : PubMed/NCBI |
|
Jaworek J, Brzozowski T and Konturek SJ: Melatonin as an organoprotector in the stomach and the pancreas. J Pineal Res. 38:73–83. 2005. View Article : Google Scholar : PubMed/NCBI |
|
Iesanu MI, Zahiu CDM, Dogaru IA, Chitimus DM, Pircalabioru GG, Voiculescu SE, Isac S, Galos F, Pavel B, O'Mahony SM and Zagrean AM: Melatonin-microbiome two-sided interaction in dysbiosis-associated conditions. Antioxidants (Basel). 11:22442022. View Article : Google Scholar : PubMed/NCBI |
|
Luo J, Song J, Zhang H, Zhang F, Liu H, Li L, Zhang Z, Chen L, Zhang M, Lin D, et al: Melatonin mediated Foxp3-downregulation decreases cytokines production via the TLR2 and TLR4 pathways in H. pylori infected mice. Int Immunopharmacol. 64:116–122. 2018. View Article : Google Scholar : PubMed/NCBI |
|
Choudhary P, Roy T, Chatterjee A, Mishra VK, Pant S and Swarnakar S: Melatonin rescues swim stress induced gastric ulceration by inhibiting matrix metalloproteinase-3 via down-regulation of inflammatory signaling cascade. Life Sci. 297:1204262022. View Article : Google Scholar : PubMed/NCBI |
|
Chen KH, Zeng BY, Zeng BS, Sun CK, Cheng YS, Su KP, Wu YC, Chen TY, Lin PY, Liang CS, et al: The efficacy of exogenous melatonin supplement in ameliorating irritable bowel syndrome severity: A meta-analysis of randomized controlled trials. J Formos Med Assoc. 122:276–285. 2023. View Article : Google Scholar : PubMed/NCBI |
|
Kvetnoi IM and Levin IM: Daily excretion of melatonin in patients with cancer of the stomach and large intestine. Vopr Onkol. 33:29–32. 1987.PubMed/NCBI |
|
Colombo F, Iannotta F, Fachinetti A, Giuliani F, Cornaggia M, Finzi G, Mantero G, Fraschini F, Malesci A, Bersani M, et al: Changes in hormonal and biochemical parameters in gastric adenocarcinoma. Minerva Endocrinol. 16:127–139. 1991.(In Italian). PubMed/NCBI |
|
Lv JW, Zheng ZQ, Wang ZX, Zhou GQ, Chen L, Mao YP, Lin AH, Reiter RJ, Ma J, Chen YP and Sun Y: Pan-cancer genomic analyses reveal prognostic and immunogenic features of the tumor melatonergic microenvironment across 14 solid cancer types. J Pineal Res. 66:e125572019. View Article : Google Scholar : PubMed/NCBI |
|
Wang Y, Song J, Li Y, Lin C, Chen Y, Zhang X and Yu H: Melatonin inhibited the progression of gastric cancer induced by Bisphenol S via regulating the estrogen receptor 1. Ecotoxicol Environ Saf. 259:1150542023. View Article : Google Scholar : PubMed/NCBI |
|
Wang K, Cai R, Fei S, Chen X, Feng S, Zhang L, Liu H, Zhang Z, Song J and Zhou R: Melatonin enhances anti-tumor immunity by targeting macrophages PD-L1 via exosomes derived from gastric cancer cells. Mol Cell Endocrinol. 568–569. 1119172023. |
|
Shi X, Li H, Dan Z, Shu C, Zhu R, Yang Q, Wang Y and Zhu H: Melatonin potentiates sensitivity to 5-fluorouracil in gastric cancer cells by upregulating autophagy and downregulating myosin light-chain kinase. J Cancer. 14:2608–2618. 2023. View Article : Google Scholar : PubMed/NCBI |
|
Cheng L, Li S, He K, Kang Y, Li T, Li C, Zhang Y, Zhang W and Huang Y: Melatonin regulates cancer migration and stemness and enhances the anti-tumour effect of cisplatin. J Cell Mol Med. 27:2215–2227. 2023. View Article : Google Scholar : PubMed/NCBI |
|
Lissoni P, Barni S, Mandala M, Ardizzoia A, Paolorossi F, Vaghi M, Longarini R, Malugani F and Tancini G: Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur J Cancer. 35:1688–1692. 1999. View Article : Google Scholar : PubMed/NCBI |
|
Li Z, Shi C, Zheng J, Guo Y, Fan T, Zhao H, Jian D, Cheng X, Tang H and Ma J: Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma. BMC Microbiol. 21:3012021. View Article : Google Scholar : PubMed/NCBI |
|
Marrero-Rodríguez D, Taniguchi-Ponciano K, Subramaniam M, Hawse JR, Pitel KS, Arreola-De la Cruz H, Huerta-Padilla V, Ponce-Navarrete G, Figueroa-Corona MDP, Gomez-Virgilio L, et al: Krüppel-Like Factor 10 participates in cervical cancer immunoediting through transcriptional regulation of Pregnancy-Specific Beta-1 Glycoproteins. Sci Rep. 8:94452018. View Article : Google Scholar : PubMed/NCBI |
|
Gu L, Feng C, Li M, Hong Z, Di W and Qiu L: Exosomal NOX1 promotes tumor-associated macrophage M2 polarization-mediated cancer progression by stimulating ROS production in cervical cancer: A preliminary study. Eur J Med Res. 28:3232023. View Article : Google Scholar : PubMed/NCBI |
|
Li Y, Han S, Wu B, Zhong C, Shi Y, Lv C, Fu L, Zhang Y, Lang Q, Liang Z, et al: CXCL11 correlates with immune infiltration and impacts patient immunotherapy efficacy: A pan-cancer analysis. Front Immunol. 13:9512472022. View Article : Google Scholar : PubMed/NCBI |
|
Wedegaertner H, Pan WA, Gonzalez CC, Gonzalez DJ and Trejo J: The alpha-arrestin ARRDC3 is an emerging multifunctional adaptor protein in cancer. Antioxid Redox Signal. 36:1066–1079. 2022. View Article : Google Scholar : PubMed/NCBI |
|
Li JP, Zhang XM, Liu BC, Ren SG, Zhao XH and Liu YJ: Comprehensive analysis of the PTPN13 expression and its clinical implication in breast cancer. Neoplasma. 70:188–198. 2023. View Article : Google Scholar : PubMed/NCBI |
|
Shan Z, Li Y, Yu S, Wu J, Zhang C, Ma Y, Zhuang G, Wang J, Gao Z and Liu D: CTCF regulates the FoxO signaling pathway to affect the progression of prostate cancer. J Cell Mol Med. 23:3130–3139. 2019. View Article : Google Scholar : PubMed/NCBI |
|
Kim J, Hu Z, Cai L, Li K, Choi E, Faubert B, Bezwada D, Rodriguez-Canales J, Villalobos P, Lin YF, et al: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells. Nature. 546:168–172. 2017. View Article : Google Scholar : PubMed/NCBI |
|
Zhou Y, Zhou X, Huang X, Hong T, Zhang K, Qi W, Guo M and Nie S: Lysosome-mediated cytotoxic autophagy contributes to tea polysaccharide-induced colon cancer cell death via mTOR-TFEB signaling. J Agric Food Chem. 69:686–697. 2021. View Article : Google Scholar : PubMed/NCBI |
|
Bowling EA, Wang JH, Gong F, Wu W, Neill NJ, Kim IS, Tyagi S, Orellana M, Kurley SJ, Dominguez-Vidaña R, et al: Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer. Cell. 184:384–403.e21. 2021. View Article : Google Scholar : PubMed/NCBI |
|
Tsai FJ, Lai MT, Cheng J, Chao SC, Korla PK, Chen HJ, Lin CM, Tsai MH, Hua CH, Jan CI, et al: Novel K6-K14 keratin fusion enhances cancer stemness and aggressiveness in oral squamous cell carcinoma. Oncogene. 38:5113–5126. 2019. View Article : Google Scholar : PubMed/NCBI |
|
Perone Y, Farrugia AJ, Rodriguez-Meira A, Győrffy B, Ion C, Uggetti A, Chronopoulos A, Marrazzo P, Faronato M, Shousha S, et al: SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERalpha breast cancer. Nat Commun. 10:21152019. View Article : Google Scholar : PubMed/NCBI |
|
Yao S, Huang HY, Han X, Ye Y, Qin Z, Zhao G, Li F, Hu G, Hu L and Ji H: Keratin 14-high subpopulation mediates lung cancer metastasis potentially through Gkn1 upregulation. Oncogene. 38:6354–6369. 2019. View Article : Google Scholar : PubMed/NCBI |
|
Hrudka J, Fiserova H, Jelinkova K, Matej R and Waldauf P: Cytokeratin 7 expression as a predictor of an unfavorable prognosis in colorectal carcinoma. Sci Rep. 11:178632021. View Article : Google Scholar : PubMed/NCBI |
|
An Q, Liu T, Wang MY, Yang YJ, Zhang ZD, Liu ZJ and Yang B: KRT7 promotes epithelialmesenchymal transition in ovarian cancer via the TGFβ/Smad2/3 signaling pathway. Oncol Rep. 45:481–492. 2021. View Article : Google Scholar : PubMed/NCBI |
|
Eckstein M, Wirtz RM, Gross-Weege M, Breyer J, Otto W, Stoehr R, Sikic D, Keck B, Eidt S, Burger M, et al: mRNA-expression of KRT5 and KRT20 defines distinct prognostic subgroups of muscle-invasive urothelial bladder cancer correlating with histological variants. Int J Mol Sci. 19:33962018. View Article : Google Scholar : PubMed/NCBI |
|
Zhang K, Liang Y, Zhang W, Zeng N, Tang S and Tian R: KRT81 knockdown inhibits malignant progression of melanoma through regulating interleukin-8. DNA Cell Biol. 40:1290–1297. 2021. View Article : Google Scholar : PubMed/NCBI |
|
Zhang N, Zhang R, Zou K, Yu W, Guo W, Gao Y, Li J, Li M, Tai Y, Huang W, et al: Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth. Cell Death Dis. 8:e29612017. View Article : Google Scholar : PubMed/NCBI |
|
Min L, Zhao Y, Zhu S, Qiu X, Cheng R, Xing J, Shao L, Guo S and Zhang S: Integrated analysis identifies molecular signatures and specific prognostic factors for different gastric cancer subtypes. Transl Oncol. 10:99–107. 2017. View Article : Google Scholar : PubMed/NCBI |
|
Jiang QG, Xiong CF and Lv YX: Kin17 facilitates thyroid cancer cell proliferation, migration, and invasion by activating p38 MAPK signaling pathway. Mol Cell Biochem. 476:727–739. 2021. View Article : Google Scholar : PubMed/NCBI |
|
Zhong C, Chen C, Yao F and Fang W: ZNF251 promotes the progression of lung cancer by activating ERK signaling. Cancer Sci. 111:3236–3244. 2020. View Article : Google Scholar : PubMed/NCBI |
|
Xiong L, Guo W, Yang Y, Gao D, Wang J, Qu Y and Zhang Y: Tectoridin inhibits the progression of colon cancer through downregulating PKC/p38 MAPK pathway. Mol Cell Biochem. 476:2729–2738. 2021. View Article : Google Scholar : PubMed/NCBI |
|
Niu M, Zhang B, Li L, Su Z, Pu W, Zhao C, Wei L, Lian P, Lu R, Wang R, et al: Targeting HSP90 inhibits proliferation and induces apoptosis through AKT1/ERK pathway in lung cancer. Front Pharmacol. 12:7241922021. View Article : Google Scholar : PubMed/NCBI |
|
Alvarez-Artime A, Cernuda-Cernuda R, Francisco Artime N, Cepas V, Gonzalez-Menendez P, Fernadez-Vega S, Quiros-Gonzalez I, Sainz RM and Mayo JC: Melatonin-induced cytoskeleton reorganization leads to inhibition of melanoma cancer cell proliferation. Int J Mol Sci. 21:5482020. View Article : Google Scholar : PubMed/NCBI |
|
Wang SW, Tai HC, Tang CH, Lin LW, Lin TH, Chang AC, Chen PC, Chen YH, Wang PC, Lai YW and Chen SS: Melatonin impedes prostate cancer metastasis by suppressing MMP-13 expression. J Cell Physiol. 236:3979–3990. 2021. View Article : Google Scholar : PubMed/NCBI |
|
Chao CC, Chen PC, Chiou PC, Hsu CJ, Liu PI, Yang YC, Reiter RJ, Yang SF and Tang CH: Melatonin suppresses lung cancer metastasis by inhibition of epithelial-mesenchymal transition through targeting to Twist. Clin Sci (Lond). 133:709–722. 2019. View Article : Google Scholar : PubMed/NCBI |
|
Proietti S, Catizone A, Masiello MG, Dinicola S, Fabrizi G, Minini M, Ricci G, Verna R, Reiter RJ, Cucina A and Bizzarri M: Increase in motility and invasiveness of MCF7 cancer cells induced by nicotine is abolished by melatonin through inhibition of ERK phosphorylation. J Pineal Res. 64:e124672018. View Article : Google Scholar : PubMed/NCBI |